Publication Information

{'id': 'https://openalex.org/W1898869012', 'doi': 'https://doi.org/10.1684/hma.2006.0063', 'title': 'Critères et traitement des réponses insuffisantes à l’imatinib dans la leucémie myéloïde chronique', 'display_name': 'Critères et traitement des réponses insuffisantes à l’imatinib dans la leucémie myéloïde chronique', 'publication_year': 2006, 'publication_date': '2006-12-01', 'ids': {'openalex': 'https://openalex.org/W1898869012', 'doi': 'https://doi.org/10.1684/hma.2006.0063', 'mag': '1898869012'}, 'language': 'fr', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://www.jle.com/en/revues/hma/e-docs/criteres_et_traitement_des_reponses_insuffisantes_a_limatinib_dans_la_leucemie_myeloide_chronique_272144/article.phtml', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4210211444', 'display_name': 'Hématologie', 'issn_l': '1264-7527', 'issn': ['1264-7527', '1766-0327', '1950-6368'], 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4310320125', 'host_organization_name': 'John Libbey Eurotext', 'host_organization_lineage': ['https://openalex.org/P4310320125'], 'host_organization_lineage_names': ['John Libbey Eurotext'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5107866515', 'display_name': 'Philippe Rousselot', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': True, 'raw_author_name': 'Philippe Rousselot', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': ['https://openalex.org/A5107866515'], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 2, 'citation_normalized_percentile': {'value': 0.508889, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 68, 'max': 72}, 'biblio': {'volume': '12', 'issue': '5', 'first_page': '19', 'last_page': '25'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11215', 'display_name': 'Chronic Myeloid Leukemia Treatments', 'score': 0.9994, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11215', 'display_name': 'Chronic Myeloid Leukemia Treatments', 'score': 0.9994, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/imatinib-mesylate', 'display_name': 'Imatinib Mesylate', 'score': 0.43603075}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.7673483}, {'id': 'https://openalex.org/C29456083', 'wikidata': 'https://www.wikidata.org/wiki/Q1221899', 'display_name': 'Gynecology', 'level': 1, 'score': 0.7237848}, {'id': 'https://openalex.org/C3019892230', 'wikidata': 'https://www.wikidata.org/wiki/Q177094', 'display_name': 'Imatinib mesylate', 'level': 4, 'score': 0.43603075}, {'id': 'https://openalex.org/C2777583451', 'wikidata': 'https://www.wikidata.org/wiki/Q177094', 'display_name': 'Imatinib', 'level': 3, 'score': 0.18815887}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.05218509}, {'id': 'https://openalex.org/C2778729363', 'wikidata': 'https://www.wikidata.org/wiki/Q11688946', 'display_name': 'Myeloid leukemia', 'level': 2, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://www.jle.com/en/revues/hma/e-docs/criteres_et_traitement_des_reponses_insuffisantes_a_limatinib_dans_la_leucemie_myeloide_chronique_272144/article.phtml', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4210211444', 'display_name': 'Hématologie', 'issn_l': '1264-7527', 'issn': ['1264-7527', '1766-0327', '1950-6368'], 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4310320125', 'host_organization_name': 'John Libbey Eurotext', 'host_organization_lineage': ['https://openalex.org/P4310320125'], 'host_organization_lineage_names': ['John Libbey Eurotext'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.8, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': [], 'abstract_inverted_index': {'Auteur(s)': [0], ':': [1], 'Philippe': [2], 'Rousselot': [3], 'Service': [4], 'd’hematologie': [5], 'et': [6], 'd’oncologie,': [7], 'Hopital': [8], 'Mignot,': [9], '177,': [10], 'rue': [11], 'de': [12, 30, 41, 43, 53, 61], 'Versailles,': [13], '78157': [14], 'Le': [15], 'Chesnay,': [16], 'France': [17], 'Les': [18], 'resultats': [19], 'du': [20], 'traitement': [21, 68], 'par': [22], 'imatinib': [23], 'mesylate': [24], '(IM)': [25], 'chez': [26], 'les': [27], 'patients': [28, 50], 'atteints': [29], 'leucemie': [31], 'myeloide': [32], 'chronique': [33], '(LMC)': [34], 'sont': [35], 'actuellement': [36], 'analyses': [37], 'avec': [38], 'un': [39], 'recul': [40], 'plus': [42], 'quatre': [44], 'ans.': [45], 'La': [46], 'survie': [47], 'globale': [48], 'des': [49], 'traites': [51], 'est': [52], '92,6\xa0%': [54], 'a': [55], '54\xa0mois': [56], '[1].': [57], 'Alors': [58], 'qu’a': [59], 'l’epoque': [60], 'l’interferon': [62], 'alpha': [63], 'recombinant,': [64], 'toute': [65], 'reponse': [66], 'au': [67], '[...]': [69]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1898869012', 'counts_by_year': [], 'updated_date': '2024-12-15T17:19:05.608015', 'created_date': '2016-06-24'}